Meet the Investors

Anna Faddeva



Anna Faddeeva, PhD | Senior Innovation Credit Adviser | Rijksdienst voor Ondernemend Nederland (RVO)

At the Netherlands Enterprise Agency (RVO), Anna Faddeeva specializes in financing high-risk medical innovations, including drug development, med-tech, and digital health. Through Innovation Credit, RVO supports technically and clinically challenging projects when private funding alone is insufficient. We provide financing from proof of concept to commercialization, covering up to 45% of costs, with a maximum credit of €10 mln. for technical projects and €5 mln. for clinical projects.








About Rijksdienst voor Ondernemend Nederland (RVO)

The Netherlands Enterprise Agency (RVO), a government agency that’s part of the Dutch Ministry of Economic Affairs, helps entrepreneurs and organizations to invest and develop their businesses and projects. The Innovation Credit is intended for the advancement of innovative development projects, with considerable technological risks and an excellent market perspective, and contributes to the innovative capacity and sustainable growth of the Dutch economy. The Innovation Credit enables the government to fulfil a need on the capital market, in which innovative projects cannot be financed entirely from private funds or the market. All companies, including start-ups and established businesses, can benefit from the Innovation Credit. https://english.rvo.nl/subsidies-programmes/innovation-credit

Powered by:
Hyphen Projects   

    Connect     

Join Global Investor Forum

Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
         
 
 

                                    

          SUBSCRIBE TO OUR NEWSLETTER
 
© Copyright 2023 by Hyphen Projects